Cell Marque IVD antibodies are only tested for use on human tissue in a clinical setting with immunohistochemistry only. No other methods such as Fluorescence or Flow Cytometry or western blot or other species such as mouse, rabbit, monkey, etc. have been qualified to work with those antibodies.
405M-1
FOXA1 (2F83) Mouse Monoclonal Antibody
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
| A ustedes/SKU | Disponibilidad | Precio |
|---|
Acerca de este artículo
NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
2F83, monoclonal
Application:
IHC (p)
Citations:
2
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarlebiological source
mouse
conjugate
unconjugated
antibody form
culture supernatant
antibody product type
primary antibodies
clone
2F83, monoclonal
description
For In Vitro Diagnostic Use in Select Regions (See Chart)
form
buffered aqueous solution
species reactivity
human
packaging
vial of 0.1 mL concentrate (405M-14), vial of 0.5 mL concentrate (405M-15), bottle of 1.0 mL predilute (405M-17), vial of 1.0 mL concentrate (405M-16), bottle of 7.0 mL predilute (405M-18)
manufacturer/tradename
Cell Marque®
technique(s)
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:25-1:100
isotype
IgG1κ
control
breast carcinoma
shipped in
wet ice
storage temp.
2-8°C
visualization
nuclear
Gene Information
human ... FOXA1(3169)
General description
Forkhead box A1 (FOXA1), also known as hepatocyte nuclear factor 3 alpha(HNF3a), is a transcription factor expressed in normal breast ductal epithelium and other epithelium in different organs, such as lung, pancreas, bladder, prostate, and colon. It has been reported to co-express with ER in breast carcinoma, predominantly in luminal subtype A.[1][2] FOXA1 expression has been identified in 42% - 75% of invasive carcinoma of the breast.[1][2] Of the FOXA1-positive breast invasive carcinomas, 83% were comprised of ER+/PR+/Her2+ luminal A subtype.[1] The results indicate that anti-FOXA1 is useful in the sub-classification of breast carcinoma.
Physical form
Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
Preparation Note
Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.
Analysis Note
 IVD |  IVD |  IVD |  RUO |
Other Notes
FOXA1 Positive Control Slides, Product No. 405S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
For Technical Service please contact: 800-665-7284 or email: [email protected]
Legal Information
Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany
1 of 1
Este artículo | |||
|---|---|---|---|
| conjugate unconjugated | conjugate unconjugated | conjugate unconjugated | conjugate - |
| species reactivity human | species reactivity human, mouse | species reactivity human | species reactivity mouse, human |
| biological source mouse | biological source mouse | biological source rabbit | biological source rabbit |
| clone 2F83, monoclonal | clone 2F83, monoclonal | clone polyclonal | clone polyclonal |
| antibody form culture supernatant | antibody form purified antibody | antibody form affinity isolated antibody | antibody form - |
| form buffered aqueous solution | form - | form - | form - |
Still not finding the right product?
Pruebe nuestra Herramienta de selección de productos para limitar sus opciones
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
-
Does the FOXA1 (2F83) antibody only react to human cells, or does it also react to mouse cells?
1 respuesta-
¿Le ha resultado útil?
-